The Truth Is In…

July 2nd, 2007

Who ever said, "vino veritas" (in wine, there is truth), hasn’t written enough. I say, "in writing veritas."   MarketWatch asked me to write an article about one’s investment strategy in the interest rate environment on the horizon.  When I first sat down to write, I thought that I was a bit neutral on the direction of interest rates. However, by the time I finished (as you’ll see), it was painfully obvious that interest rates are more likely to go down than up. It’s a story of global prosperity that has been in part prepped up by finite sources (mostly debt).

I would not bet my career or even a bottle of fine beer (Fat Tire - those in Colorado will know), but there are too many "uncertainties" on the horizon for higher interest rates.  In the article, I offered two stocks, Glaxosmithkline (GSK) and Johnson & Johnson (JNJ)  that should do well in any interest rate environment.

Add to del.icio.us | Digg this story

Entry Filed under: Analysis & Research

3 Comments Add your own

  • 1. David  |  July 3rd, 2007 at 12:53 am

    Nice article and exposure at Marketwatch.

    David

  • 2. TIm  |  July 3rd, 2007 at 1:24 pm

    Nice article. I like your writing style … it’s succint with a touch of humor. Your honesty (i.e., who knows where interest rates are going to go …) is refreshing. I look forward to reading your book in September. TIM

  • 3. Vitaliy  |  July 3rd, 2007 at 3:33 pm

    Thank you very much!!!

Leave a Comment

Required

Required, hidden

Some HTML allowed:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

Trackback this post  |  Subscribe to the comments via RSS Feed



Categories

The Best Of